首页> 外国专利> Process for the preparation of antigen-specific cytotoxic cells with activity against BREAST CANCER CELLS

Process for the preparation of antigen-specific cytotoxic cells with activity against BREAST CANCER CELLS

机译:具有抗乳腺癌细胞活性的抗原特异性细胞毒性细胞的制备方法

摘要

1. A method for producing antigen-specific cytotoxic cells having anti-tumor activity against breast cancer cells, comprising the following steps: a) isolating mononuclear cells (MNC) from peripheral blood of a patient, and b) cultivating MNCs division adhering cells and non-adherent fraction, in ) growing adherent MNC fraction in the presence of growth factors to obtain mature dendritic cells (DC), d) transfection of mature DC with expression plasmids containing a DNA vaccine constructs for diruyuschimi versatile and HLA-A * 0201-specific epitopes major tumor-associated antigens recognized by cytotoxic T lymphocytes (CTL) and T-cell helper (Th); d) co-culturing of mature DC obtained in step d) and nonstick MNC fraction in the presence of recombinant human IL-12 and recombinant human interleukin-18.2. A method according to claim 1, characterized in that as growth factors for growing adherent MNC fraction using granulocyte macrophage colony-stimulating factor (GM-CSF) and human interleukin-4 (IL-4) human.
机译:1.一种产生对乳腺癌细胞具有抗肿瘤活性的抗原特异性细胞毒性细胞的方法,其包括以下步骤:a)从患者外周血中分离单核细胞(MNC),和b)培养MNCs分裂粘附细胞和非粘附部分,在存在生长因子的情况下,在生长中的粘附MNC部分中获得成熟的树突状细胞(DC),d)用含有质粒的表达质粒转染成熟的DC,该DNA疫苗构建物适用于diruyuschimi多用途和HLA-A * 0201-细胞毒性T淋巴细胞(CTL)和T细胞辅助细胞(Th)识别的特定表位主要的肿瘤相关抗原; d)在重组人IL-12和重组人白介素18.2存在下,共培养步骤d)中获得的成熟DC和不粘MNC级分。 2.根据权利要求1所述的方法,其特征在于,使用粒细胞巨噬细胞集落刺激因子(GM-CSF)和人白细胞介素-4(IL-4)作为生长粘附的MNC级分的生长因子。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号